Q1 2026 SANUWAVE Health Inc Earnings Call Transcript
Key Points
- SANUWAVE Health Inc (SNWV) achieved the highest Q1 revenues in company history, surpassing the previous year's record by 3%.
- Consumables utilization grew by 22% year-over-year and 4% sequentially from Q4 2025, indicating strong demand.
- The company sold 97 systems in Q1, increasing the number of active systems to 1,382 from 1,292 at year-end.
- There is renewed interest and progress in mobile wound care, with SANUWAVE Health Inc (SNWV) seeing opportunities in long-term care and nursing facilities.
- The company is experiencing increased engagement from large systems, which could lead to significant growth opportunities in the second half of the year.
- The advanced wound care market experienced a shock pause in January due to unexpected CMS pricing changes, affecting initial performance.
- Gross margin decreased by 177 basis points year-over-year, primarily due to a shift to wholesale pricing for resellers.
- Operating loss for Q1 2026 was $1.1 million, a significant swing from the operating income of $0.6 million in the same period last year.
- Operating expenses increased by $1.8 million year-over-year, driven by higher non-cash stock-based compensation, payroll, and R&D expenses.
- The rural market poses challenges due to lower pay rates and high travel costs, which may require re-indexing or payment adjustments.
Please stand by, your meeting is about to begin. Hello and welcome everyone joining today's SANUWAVE earnings call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. To register to ask a question at any time, please press *1 on your telephone keypad. Please note, this call is being recorded. We are standing by if you should need any assistance.
It is now my pleasure to turn the meeting over to Morgan Frank, Chairman and CEO of SANUWAVE. Please go ahead.
Thank you, Nikki.
Welcome to SANUWAVE's first-quarter 2026 earnings call. Our Form 10-Q was filed with the SEC last night, along with our earnings release and our updated presentation was made available on our website in the Investor section. Please refer to that during the presentation. Joining me on the call is Peter Sorensen, our CFO, and after the presentation, we will open up for Q&A. So let's begin
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
